Skip to content
Screener

Reported November 12, 2026 · Before market open

EPS-$0.11Beat by $0.04
Revenue estimate$1.0M
EPS estimate-$0.15

Next report

Feb 15, 2027 (in 3 months)
Revenue estimate$2.3M
EPS estimate-$0.15

FAQ

When did Grace Therapeutics, Inc. report Q3 2026 earnings?
Grace Therapeutics, Inc. (GRCE) reported Q3 2026 earnings on November 12, 2026 before market open.
What were Grace Therapeutics, Inc.'s Q3 2026 revenue and EPS?
Grace Therapeutics, Inc. reported eps of $-0.11 for Q3 2026.
Did Grace Therapeutics, Inc. beat estimates in Q3 2026?
EPS beat the consensus estimate of $-0.15 by $0.04.
How did Grace Therapeutics, Inc.'s Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 26.7% from $-0.15.
Where can I find Grace Therapeutics, Inc.'s Q3 2026 SEC filings?
You can read the 8-K earnings release (0001140361-26-043308) and the 10-Q periodic report (0001140361-26-043299) directly on SEC EDGAR. The filing index links above go to sec.gov.